Search
American Healthcare REIT Inc
AHRAdd to Watchlist
46.520USD
-0.030-0.06%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
8.97BMarket Cap
78.80P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of American Healthcare REIT Inc is 8.33, ranking 12 out of 191 in the Residential & Commercial REITs industry. The average price target is 55.50, with a high of 60.00 and a low of 52.00.
Analyst Rating
Based on
13
analysts
Buy
Current Rating
58.231
Target Price
+25.17%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
8
Median
9
Average
Company name
Ratings
Analysts
American Healthcare REIT Inc
AHR
13
Equinix Inc
EQIX
33
Digital Realty Trust Inc
DLR
33
American Tower Corp
AMT
25
VICI Properties Inc
VICI
25
Gaming and Leisure Properties Inc
GLPI
24
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is American Healthcare REIT Inc's expected revenue for the next quarter?
American Healthcare REIT Inc's expected revenue is 659.93M.
What is American Healthcare REIT Inc's price target?
Analysts forecast that American Healthcare REIT Inc's price target is USD 55.50, with the highest forecast at USD 60.00 and the lowest forecast at USD 52.00.
How have American Healthcare REIT IncAHR's recent earnings per share performed?
The market expectation was USD 0.13, while American Healthcare REIT IncAHR's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.16.
What is the analyst rating for American Healthcare REIT Inc?
Based on the ratings of American Healthcare REIT Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
